Fusobacterium nucleatum: An emerging gut pathogen?

Gut Microbes

Volumn 2, Issue 5, 2011, Pages 294-298

  Allen Vercoe, Emma ^a   Strauss, Jaclyn ^a   Chadee, Kris ^b  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Chemokines; Fusobacteria; Fusobacterium nucleatum; Gastrointestinal infection; Inflammatory bowel diseases; Mucin

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 8; MATRIX METALLOPROTEINASE; MEMBRANE COFACTOR PROTEIN; MUCIN 1; MUCIN 2; MUCIN 3; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELL FUNCTION; COLON CANCER; DIGESTIVE SYSTEM DISEASE; ENTERITIS; FUSOBACTERIUM NUCLEATUM; GENE EXPRESSION; HOST CELL; HUMAN; IN VIVO CULTURE; LYMPHOCYTE; NONHUMAN; PATHOGENICITY; PORPHYROMONAS GINGIVALIS; STREPTOCOCCUS PYOGENES; TANNERELLA FORSYTHENSIS; TREPONEMA DENTICOLA;

EID: 83255187024     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.2.5.18603     Document Type: Article

References (47)

1. Citron DM. Update on the taxonomy and clinical aspects of the genus Fusobacterium. Clin Infect Dis 2002; 35:22-27. PMID:12173104; DOI:10.1086/341916.
2. Kolenbrander PE, Palmer RJ Jr, Rickard AH, Jakubovics NS, Chalmers NI, Diaz PI. Bacterial interactions and successions during plaque development. Periodontol 2006; 42:47-79. PMID:16930306; DOI:10.1111/j.1600-0757.2006.00187.x.
3. Strauss J, White A, Ambrose C, McDonald J, Allen-Vercoe E. Phenotypic and genotypic analyses of clinical Fusobacterium nucleatum and Fusobacterium periodonticum isolates from the human gut. Anaerobe 2008; 14:301-309. PMID:19114111; DOI:10.1016/j.anaerobe.2008.12.003.
4. Suchett-Kaye G, Decoret D, Barsotti O. Clonal analysis by ribotyping of Fusobacterium nucleatum isolates obtained from healthy young adults with optimal plaque control. J Periodontal Res 1998; 33:179-86. PMID:9689613; DOI:10.1111/j.1600-0765.1998.tb02189.x.
5. Thurnheer T, Guggenheim B, Gruica B, Gmür R. Infinite serovar and ribotype heterogeneity among oral Fusobacterium nucleatum strains? Anaerobe 1999; 5:79-92. DOI:10.1006/anae.1999.0188.
6. Morris ML, Andrews RH, Rogers AH. Investigations of the taxonomy and systematics of Fusobacterium nucleatum using allozyme electrophoresis. Int J Syst Bacteriol 1997; 47:103-110. PMID:8995811; DOI:10.1099/00207713-47-1-103.
7. Gmür R, Munson MA, Wade WG. Genotypic and phenotypic characterization of fusobacteria from Chinese and European patients with inflammatory periodontal diseases. Syst Appl Microbiol 2006; 29:120-130. PMID:16464693; DOI:10.1016/j.syapm.2005.07.011.
8. Strauss J, Kaplan GG, Beck PL, Rioux K, Panaccione R, Devinney R, et al. Invasive potential of gut mucosa- derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis 2011; 17:1971-1978. PMID:21830275; DOI:10.1002/ibd.21606.
9. Shammas NW, Murphy GW, Eichelberger J, Klee D, Schwartz R, Bachman W. Infective endocarditis due to Fusobacterium nucleatum: case report and review of the literature. Clin Cardiol 1993; 16:72-75. PMID:8416766; DOI:10.1002/clc.4960160116.
10. Brook I, de Leyva F. Microbiology of tonsillar surfaces in infectious mononucleosis. Arch Pediatr Adolesc Med 1994; 148:171-173. PMID:8118535.
11. Roberts GL. Fusobacterial infections: an underestimated threat. Br J Biomed Sci 2000; 57:156-162. PMID:10912293.
12. Marina M, Strong CA, Civen R, Molitoris E, Finegold SM. Bacteriology of anaerobic pleuropulmonary infections: preliminary report. Clin Infect Dis 1993; 16:256-262. PMID:8324128; DOI:10.1093/clinids/16.Supplement_4.S256.
13. Cahill RJ, Tan S, Dougan G, O'gaora P, Pickard D, Kennea N, et al. Universal DNA primers amplify bacterial DNA from human fetal membranes and link Fusobacterium nucleatum with prolonged preterm membrane rupture. Mol Hum Reprod 2005; In press. PMID:16254004; DOI:10.1093/molehr/gah234.
14. Bearfield C, Davenport ES, Sivapathasundaram V, Allaker RP. Possible association between amniotic fluid micro-organism infection and microflora in the mouth. BJOG 2002; 109:527-533. PMID:12066942; DOI:10.1111/j.1471-0528.2002.01349.x.
15. Han YW, Redline RW, Li M, Yin L, Hill GB, McCormick TS. Fusobacterium nucleatum induces premature and term stillbirths in pregnant mice: implication of oral bacteria in preterm birth. Infect Immun 2004; 72:2272-2279. PMID:15039352; DOI:10.1128/IAI.72.4.2272-9.2004.
16. Moore WE, Moore LV. The bacteria of periodontal diseases. Periodontol 1994; 5:66-77. PMID:9673163; DOI:10.1111/j.1600-0757.1994.tb00019.x.
17. Han YW, Shi W, Huang GT, Kinder Haake S, Park NH, Kuramitsu H, et al. Interactions between periodontal bacteria and human oral epithelial cells: Fusobacterium nucleatum adheres to and invades epithelial cells. Infect Immun 2000; 68:3140-3146. PMID:10816455; DOI:10.1128/IAI.68.6.3140-6.2000.
18. Swidsinski A, Dorffel Y, Loening-Baucke V, Theissig F, Ruckert JC, Ismail M, et al. Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum. Gut 2011; 60:34-40. PMID:19926616; DOI:10.1136/gut.2009.191320.
19. Dabija-Wolter G, Cimpan MR, Costea DE, Johannessen AC, Sornes S, Neppelberg E, et al. Fusobacterium nucleatum enters normal human oral fibroblasts in vitro. J Periodontol 2009; 80:1174-1183. PMID:19563299; DOI:10.1902/jop.2009.090051.
20. Peterson J, Garges S, Giovanni M, McInnes P, Wang L, Schloss JA, et al. The NIH Human Microbiome Project. Genome Res 2009; 19:2317-2323. PMID:19819907; DOI:10.1101/gr.096651.109.
21. Brandtzaeg P. Inf lammatory bowel disease: clinics and pathology. Do inf lammatory bowel disease and periodontal disease have similar immunopathogeneses? Acta Odontol Scand 2001; 59:235-243. PMID:11570527; DOI:10.1080/00016350152509265.
22. Harty S, Fleming P, Rowland M, Crushell E, McDermott M, Drumm B, et al. A prospective study of the oral manifestations of Crohn's disease. Clin Gastroenterol Hepatol 2005; 3:886-891. PMID:16234026; DOI:10.1016/S1542-3565(05)00424-6.
23. Halme L, Meurman JH, Laine P, von Smitten K, Syrjanen S, Lindqvist C, et al. Oral findings in patients with active or inactive Crohn's disease. Oral Surg Oral Med Oral Pathol 1993; 76:175-181. PMID:8361727; DOI:10.1016/0030-4220(93)90200-N.
24. van Dyke TE, Dowell VR Jr, Offenbacher S, Snyder W, Hersh T. Potential role of microorganisms isolated from periodontal lesions in the pathogenesis of inflammatory bowel disease. Infect Immun 1986; 53:671-677. PMID:3462153.
25. Moore WE, Holdeman LV, Cato EP, Smibert RM, Burmeister JA, Palcanis KG, et al. Comparative bacteriology of juvenile periodontitis. Infect Immun 1985; 48:507-519. PMID:3988344.
26. Gupta S, Ghosh SK, Scott ME, Bainbridge B, Jiang B, Lamont RJ, et al. Fusobacterium nucleatum-associated beta-defensin inducer (FAD-I): identification, isolation and functional evaluation. J Biol Chem 2010; 285:36523-36531. PMID:20847052; DOI:10.1074/jbc.M110.133140.
27. Gursoy UK, Kononen E, Uitto VJ. Stimulation of epithelial cell matrix metalloproteinase (MMP- 2, -9, -13) and interleukin-8 secretion by fusobacteria. Oral Microbiol Immunol 2008; 23:432-434. PMID:18793368; DOI:10.1111/j.1399-302X.2008.00453.x.
28. Signat B, Roques C, Poulet P, Duffaut D. Fusobacterium nucleatum in Periodontal Health and Disease. Curr Issues Mol Biol 2011; 13:25-36. PMID:21220789.
29. Saito A, Inagaki S, Kimizuka R, Okuda K, Hosaka Y, Nakagawa T, et al. Fusobacterium nucleatum enhances invasion of human gingival epithelial and aortic endothelial cells by Porphyromonas gingivalis. FEMS Immunol Med Microbiol 2008; 54:349-355. PMID:19049647; DOI:10.1111/j.1574-695X.2008.00481.x.
30. Metzger Z, Blasbalg J, Dotan M, Tsesis I, Weiss EI. Characterization of coaggregation of Fusobacterium nucleatum PK1594 with six Porphyromonas gingivalis strains. J Endod 2009; 35:50-54. PMID:19084124; DOI:10.1016/j.joen.2008.09.016.
31. Stathopoulou PG, Benakanakere MR, Galicia JC, Kinane DF. Epithelial cell pro-inflammatory cytokine response differs across dental plaque bacterial species. J Clin Periodontol 2010; 37:24-29. PMID:20096064; DOI:10.1111/j.1600-051X.2009.01505.x.
32. Kaplan CW, Ma X, Paranjpe A, Jewett A, Lux R, Kinder-Haake S, et al. Fusobacterium nucleatum outer membrane proteins Fap2 and RadD induce cell death in human lymphocytes. Infect Immun 2010; 78:4773-4778. PMID:20823215; DOI:10.1128/IAI.00567-10.
33. Mahtout H, Chandad F, Rojo JM, Grenier D. Fusobacterium nucleatum binding to complement regulatory protein CD46 modulates the expression and secretion of cytokines and matrix metalloproteinases by oral epithelial cells. J Periodontol 2011; 82:311-319. PMID:20843232; DOI:10.1902/jop.2010.100458.
34. Cattaneo R. Four viruses, two bacteria and one receptor: membrane cofactor protein (CD46) as pathogens' magnet. J Virol 2004; 78:4385-4388. PMID:15078919; DOI:10.1128/JVI.78.9.4385-8.2004.
35. Xu M, Yamada M, Li M, Liu H, Chen SG, Han YW. FadA from Fusobacterium nucleatum utilizes both secreted and nonsecreted forms for functional oligomerization for attachment and invasion of host cells. J Biol Chem 2007; 282:25000-25009. PMID:17588948; DOI:10.1074/jbc.M611567200.
36. Gursoy UK, Kononen E, Uitto VJ. Intracellular replication of fusobacteria requires new actin filament formation of epithelial cells. APMIS 2008; 116:1063-1070. PMID:19133009; DOI:10.1111/j.1600-0463.2008.00868.x.
37. Silva VL, Diniz CG, Cara DC, Santos SG, Nicoli JR, Carvalho MA, et al. Enhanced pathogenicity of Fusobacterium nucleatum adapted to oxidative stress. Microb Pathog 2005; 39:131-138. PMID:16125361; DOI:10.1016/j.micpath.2005.07.002.
38. Ji S, Shin JE, Kim YC, Choi Y. Intracellular degradation of Fusobacterium nucleatum in human gingival epithelial cells. Mol Cells 2010; 30:519-526. PMID:21057979; DOI:10.1007/s10059-010-0142-8.
39. Parkin DM. The global health burden of infection- associated cancers in the year 2002. Int J Cancer 2006; 118:3030-3044. PMID:16404738; DOI:10.1002/ijc.21731.
40. Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 2011; In press.
41. Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 2011; In press.
42. Pryde SE, Duncan SH, Hold GL, Stewart CS, Flint HJ. The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett 2002; 217:133-139. PMID:12480096; DOI:10.1111/j.1574-6968.2002.tb11467.x.
43. Roediger WE, Duncan A, Kapaniris O, Millard S. Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis. Gastroenterology 1993; 104:802-809. PMID:8440437.
44. Jakubovics NS, Gill SR, Iobst SE, Vickerman MM, Kolenbrander PE. Regulation of gene expression in a mixed-genus community: stabilized arginine biosynthesis in Streptococcus gordonii by coaggregation with Actinomyces naeslundii. J Bacteriol 2008; 190:3646-3657. PMID:18359813; DOI:10.1128/JB.00088-08.
45. Edwards AM, Grossman TJ, Rudney JD. Fusobacterium nucleatum transports noninvasive Streptococcus cristatus into human epithelial cells. Infect Immun 2006; 74:654-662. PMID:16369022; DOI:10.1128/IAI.74.1.654-62.2006.
46. Zhang G, Rudney JD. Streptococcus cristatus attenuates Fusobacterium nucleatum-induced cytokine expression by influencing pathways converging on nuclear factor-kappaB. Mol Oral Microbiol 2011; 26:150-163. PMID:21375705; DOI:10.1111/j.2041-1014.2010.00600.x.
47. Dharmani P, Strauss J, Ambrose C, Allen-Vercoe E, Chadee K. Fusobacterium nucleatum infection of colonic cells stimulates MUC2 mucin and tumor necrosis factor alpha. Infect Immun 2011; 79:2597-2607. PMID:21536792; DOI:10.1128/IAI.05118-11.